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Value of the data {#sec0001}
=================

•The data provide the first experimental evidence about the effect of the anticancer peptide LTX-315 on the distribution of cell cycle phases in normal and skin cancer cells.•Dataset allows comparison between LTX-315 concentrations and cell cycle distributions in two different skin cancer cell lines and in non-tumoral cells.•The data provide valuable information on the relationships between cell cycle distribution and cell viability in non-tumoral and skin cancer-derived cells in response to LTX-315 treatment.•Researchers can use the data as additional evidence to investigate the selectivity of the treatment with LTX-315.

2. Data {#sec0002}
=======

Histograms ([Fig. 1](#fig0001){ref-type="fig"}) and bar graphs ([Fig. 2](#fig0002){ref-type="fig"}) showed that treatment with peptide LTX-315, compared to non-treated cells, induced a sub-G1 peak in non-tumoral cells; this is a dose-dependent effect, the data are statistically different at 75 µM. The distinct sub-G1 peak might represent condensed or fragmented DNA, which was stained with low level DNA fluorescence and further suggests an apoptotic death [@bib0005],[@bib0006]. These data are in marked contrast to the effect of the peptide observed in melanoma and epidermoid carcinoma cells, in which no sub-G1 peak is evident. The analyses of the viability data after performing PI uptake assays ([Fig. 3](#fig0003){ref-type="fig"}) showed that HaCaT cells were more sensitive to LTX-315 treatment than the cancer cells.Fig. 1Cell cycle distribution in non-tumoral and cancer cells after LTX-315 treatment. Cells were treated with different concentrations of LTX-315 for 24 h. A. HaCaT, normal human keratinocyte cell line. B. A431, epidermoid carcinoma cells C. A375, melanoma cancer cells. The histograms show a representative example of the distribution of cell cycle phases in each treatment.Fig 1Fig. 2Quantification of cell cycle distribution of the total cell population in the different phases of the cell cycle. A. HaCaT, normal human keratinocyte cell line. B. A431, epidermoid carcinoma cells C. A375, melanoma cancer cells. Values are expressed as mean ± SEM of three independent experiments. Two-way ANOVA for sub-G1, G1, S and G2/M populations, difference with respect to NT, \* *p* ≤ 0.05, \*\* *p* ≤ 0.01, \*\*\*\* *p* ≤ 0.0001.Fig 2Fig. 3Cell viability percentages after treatment with LTX-315 in non-tumoral HaCaT (![](fx1.gif)), cancer cell lines A431 (![](fx2.gif)) and A375 (![](fx3.gif)). Cells were treated with different concentrations of LTX-315 for 24 h, after which propidium iodide uptake was assayed, as a measure of membrane integrity. Non-treated cells were considered as having 100% viability. Values are expressed as mean ± SEM of three independent experiments. Two-way ANOVA, difference with respect to NT, \* *p* ≤ 0.05, \*\*\*\* *p* ≤ 0.0001.Fig 3

3. Experimental design, materials, and methods {#sec0003}
==============================================

3.1. LTX {#sec0004}
--------

LTX-315 (K--K--W--W--K--K--W--Dip--K--NH~2~, Lot.91799130007/PE4961) was synthesized by the solid-phase method according to the sequence published by Camilio et al. [@bib0004] and purchased from GenScript (Piscataway Township, NJ, USA). The purity of the peptide was determined by analytical HPLC to be higher than 95%, and the molecular weight was confirmed with MALDI-TOF mass spectrometry.

3.2. Cell culture {#sec0005}
-----------------

Human skin cancer cell lines, A375 and A431, were purchased from American Type Cell Culture (ATCC). The human keratinocyte line HaCaT was employed as normal cell control. Cells were cultured at a final concentration of 2.5 × 10^5^ cells/ml in Dulbecco\'s modified Eagle\'s medium (DMEM, Gibco). The medium was complemented with 5% fetal bovine serum (FCS, Gibco) and 1% penicillin/streptomycin (Gibco). Cell cultures were incubated at 37 °C with 5% CO~2~.

3.3. Treatment outline {#sec0006}
----------------------

Cells were disaggregated using trypsin-EDTA. Cell suspensions were centrifuged at 3500 rpm for 5 min, the supernatant was discarded and cell pellets were plated in 6-well plates at a final concentration of 2.5 × 10^5^ cells/ml. After adhesion, cells were treated with different concentrations of LTX-315 (25--75 µM) for 24 h and were then processed for cell cycle and cell viability. Peptide concentrations were selected based on previous studies of LTX-315 on different tumoral cell lines [@bib0003],[@bib0007], [@bib0008], [@bib0009], [@bib0010]. In these studies, concentrations ranging from 8 to 400 µM were evaluated. However, a maximum concentration of 75 µM was considered appropriate to induce changes in the cell cycle.

3.4. Cell cycle analyses {#sec0007}
------------------------

Measuring the DNA content of cells is a well-established method to monitor cell cycle [@bib0011]. In order to analyze cell progression through the cycle, exponentially growing cells were exposed to 25 , 50  or 75 µM of LTX-315 for 24 h, washed with PBS, and then disaggregated using trypsin-EDTA. One million cells per milliliter were suspended in ice-cold 70% ethanol and fixed for 1 h at 4 °C. Next, cell suspensions were washed in PBS, treated with 100 µg/ml RNase, and incubated with 100 µg/ml propidium iodide (PI) for 30 min. PI fluorescence of 10,000 events was analyzed using a BD LSRFortessa flow cytometer. Percentages of cells in each phase were calculated using FlowJo. Each experiment was performed three times.

3.5. PI staining (cell viability analysis) {#sec0008}
------------------------------------------

One of the best markers for cell death is membrane integrity. In flow cytometry, plasma membrane permeability is assessed using propidium iodide, a dye that is not permeant to live cells [@bib0012]. To assess cell viability after 24 h of 25 , 50  or 75 µM LTX-315 treatments, cells were washed with PBS and disaggregated using trypsin-EDTA. Cell pellets were resuspended, stained with 1 mg/ml PI, and incubated in the dark at room temperature for 20 min. Following this, 10,000 events were analyzed by flow cytometry in BD LSRFortessa. Fluorescence was quantified using FlowJo. Each experiment was performed three times.

3.6. Statistical analysis {#sec0009}
-------------------------

Data were expressed as mean ± standard error of the mean. ANOVA analyses were performed using via GraphPad Prism, with post-hoc comparisons carried out by Fisher\'s protected least significant difference (FPLSD) tests. *p* ≤ 0.05 was considered statistically significant.

Appendix. Supplementary materials {#sec0013}
=================================
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